Chronic Myelomonocytic Leukemia (CMML) and Juvenile Myelomonocytic Leukemia (JMML)
No. 17 in a series providing the latest information for patients, caregivers and healthcare professionals
Introduction
Chronic myelomonocytic leukemia (CMML) and juvenile myelomonocytic leukemia (JMML) are uncommon blood cancers that have characteristics of two other types of blood cancers called "myelodysplastic syndromes" (MDS) and "myeloproliferative disorders" (MPDs). For this reason the World Health Organization (WHO) has classified CMML and JMML as "mixed myelodysplastic/myeloproliferative diseases." This is a relatively new (2001) classification that is expected to lead to greater understanding of these diseases and to the development of more effective treatments. CMML and JMML were previously classified as myelodysplastic syndromes (MDS) subtypes or atypical chronic myeloid disorders.
Continue reading by downloading the .pdf or order a free printed copy via the online order form.
If you need assistance ordering free materials please call the Information Resource Center at (800) 955-4572 or contact your local chapter.
print page
email page